Cargando…

Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity

Histone deacetylase 3 (Hdac3) regulates the expression of lipid metabolism genes in multiple tissues, however its role in regulating lipid metabolism in the intestinal epithelium is unknown. Here we demonstrate that intestine-specific deletion of Hdac3 (Hdac3(IKO)) protects mice from diet induced ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Dávalos-Salas, Mercedes, Montgomery, Magdalene K., Reehorst, Camilla M., Nightingale, Rebecca, Ng, Irvin, Anderton, Holly, Al-Obaidi, Sheren, Lesmana, Analia, Scott, Cameron M., Ioannidis, Paul, Kalra, Hina, Keerthikumar, Shivakumar, Tögel, Lars, Rigopoulos, Angela, Gong, Sylvia J., Williams, David S., Yoganantharaja, Prusoth, Bell-Anderson, Kim, Mathivanan, Suresh, Gibert, Yann, Hiebert, Scott, Scott, Andrew M., Watt, Matthew J., Mariadason, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876593/
https://www.ncbi.nlm.nih.gov/pubmed/31757939
http://dx.doi.org/10.1038/s41467-019-13180-8
Descripción
Sumario:Histone deacetylase 3 (Hdac3) regulates the expression of lipid metabolism genes in multiple tissues, however its role in regulating lipid metabolism in the intestinal epithelium is unknown. Here we demonstrate that intestine-specific deletion of Hdac3 (Hdac3(IKO)) protects mice from diet induced obesity. Intestinal epithelial cells (IECs) from Hdac3(IKO) mice display co-ordinate induction of genes and proteins involved in mitochondrial and peroxisomal β-oxidation, have an increased rate of fatty acid oxidation, and undergo marked remodelling of their lipidome, particularly a reduction in long chain triglycerides. Many HDAC3-regulated fatty oxidation genes are transcriptional targets of the PPAR family of nuclear receptors, Hdac3 deletion enhances their induction by PPAR-agonists, and pharmacological HDAC3 inhibition induces their expression in enterocytes. These findings establish a central role for HDAC3 in co-ordinating PPAR-regulated lipid oxidation in the intestinal epithelium, and identify intestinal HDAC3 as a potential therapeutic target for preventing obesity and related diseases.